1. Home
  2. PRPO vs TMDE Comparison

PRPO vs TMDE Comparison

Compare PRPO & TMDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • TMDE
  • Stock Information
  • Founded
  • PRPO N/A
  • TMDE 2016
  • Country
  • PRPO United States
  • TMDE Malaysia
  • Employees
  • PRPO N/A
  • TMDE N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • TMDE Oil Refining/Marketing
  • Sector
  • PRPO Industrials
  • TMDE Energy
  • Exchange
  • PRPO Nasdaq
  • TMDE Nasdaq
  • Market Cap
  • PRPO 22.0M
  • TMDE 24.3M
  • IPO Year
  • PRPO N/A
  • TMDE 2025
  • Fundamental
  • Price
  • PRPO $17.59
  • TMDE $0.89
  • Analyst Decision
  • PRPO
  • TMDE
  • Analyst Count
  • PRPO 0
  • TMDE 0
  • Target Price
  • PRPO N/A
  • TMDE N/A
  • AVG Volume (30 Days)
  • PRPO 16.8K
  • TMDE 42.4K
  • Earning Date
  • PRPO 11-05-2025
  • TMDE 11-11-2025
  • Dividend Yield
  • PRPO N/A
  • TMDE N/A
  • EPS Growth
  • PRPO N/A
  • TMDE N/A
  • EPS
  • PRPO N/A
  • TMDE 0.09
  • Revenue
  • PRPO $21,242,000.00
  • TMDE $688,607,542.00
  • Revenue This Year
  • PRPO N/A
  • TMDE N/A
  • Revenue Next Year
  • PRPO N/A
  • TMDE N/A
  • P/E Ratio
  • PRPO N/A
  • TMDE $10.04
  • Revenue Growth
  • PRPO 27.05
  • TMDE 8.77
  • 52 Week Low
  • PRPO $3.90
  • TMDE $0.67
  • 52 Week High
  • PRPO $22.38
  • TMDE $6.27
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 54.11
  • TMDE N/A
  • Support Level
  • PRPO $17.00
  • TMDE N/A
  • Resistance Level
  • PRPO $22.38
  • TMDE N/A
  • Average True Range (ATR)
  • PRPO 1.35
  • TMDE 0.00
  • MACD
  • PRPO -0.13
  • TMDE 0.00
  • Stochastic Oscillator
  • PRPO 40.83
  • TMDE 0.00

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About TMDE TMD Energy Limited Ordinary Shares

TMD Energy Ltd is engaged in marine fuel bunkering services specializing in the supply and marketing of marine gas oil and marine fuel oil (including high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil), to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering. It is currently operating with a fleet of nearly 15 bunkering vessels ranging from 540 dwt to 7,820 dwt, of which nearly nine (9) are double bottom and double hull vessels with an average cargo-carrying capacity of approximately 4,200 dwt each.

Share on Social Networks: